Status:

ACTIVE_NOT_RECRUITING

PrEP Affect Regulation Treatment Innovation

Lead Sponsor:

Florida International University

Collaborating Sponsors:

University of California, San Francisco

National Institute on Drug Abuse (NIDA)

Conditions:

Medication Adherence

HIV Prevention

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

This multi-site randomized controlled trial enrolling sexual minority men who use stimulants and are currently taking pre-exposure prophylaxis (PrEP). This randomized controlled trial will test the ef...

Eligibility Criteria

Inclusion

  • Assigned male at birth
  • Identifies as male
  • Age 18 or older
  • Reads and speaks English
  • Reports condomless anal sex (CAS) with men in the past 6 months
  • self-reported HIV negative
  • Active prescription for daily oral PrEP for at least 2 months and reports any non-adherence in the past month OR initiated daily oral PrEP in the past 2 months, regardless of self-reported adherence
  • Has an iPhone or Android smartphone
  • Screens positive for a moderate or severe stimulant use disorder with an abbreviated version of the Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST; total score of 4 or more) OR reports using stimulants at least weekly in the past 3 months.
  • Lives in California or Florida with no plans to move out of state in the next 6 months

Exclusion

  • Unable or unwilling to provide informed consent
  • Unwilling to upload upload 3 video recordings of directly observed PrEP doses using a smartphone application
  • Identifies as transfeminine (e.g., transgender woman)
  • Unable or Unwilling to provide dried blood spot (DBS) specimen at baseline
  • Switched from daily oral PrEP with disoproxil fumarate (TDF) to daily oral PrEP with tenofovir alafenamide (TAF) in the past 5 months

Key Trial Info

Start Date :

January 31 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2026

Estimated Enrollment :

239 Patients enrolled

Trial Details

Trial ID

NCT04899024

Start Date

January 31 2022

End Date

July 1 2026

Last Update

April 17 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94143

2

University of Miami Miller School of Medicine

Miami, Florida, United States, 33136